Prostate Cancer Breakthroughs
New FDA approval for Enzalutamide
Enzalutamide, also known under the branded name Xtandi, has recently received a new FDA approval. In 2012, Enzalutamide was approved for the treatment of Non-Metastatic
Enzalutamide, also known under the branded name Xtandi, has recently received a new FDA approval. In 2012, Enzalutamide was approved for the treatment of Non-Metastatic